Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.14%36.11B | 8.31%9.4B | 2.44%9.61B | -13.91%8.59B | -11.67%8.51B | 4.88%37.67B | -3.50%8.68B | 0.73%9.38B | 12.07%9.97B | 10.63%9.64B |
Cost of revenue | -0.11%25.5B | 2.02%6.61B | 1.31%6.56B | -3.03%6.18B | -0.82%6.15B | 9.81%25.52B | 5.56%6.48B | 6.74%6.47B | 13.81%6.37B | 13.93%6.2B |
Gross profit | -12.61%10.61B | 26.86%2.79B | 4.92%3.05B | -33.12%2.41B | -31.23%2.36B | -4.17%12.15B | -23.02%2.2B | -10.47%2.91B | 9.15%3.6B | 5.11%3.44B |
Operating expense | 7.17%7.79B | 11.35%1.97B | 8.86%1.97B | 1.04%1.94B | 7.89%1.91B | 7.01%7.27B | 5.61%1.77B | 6.55%1.81B | 12.02%1.92B | 3.80%1.77B |
Staff costs | 9.95%1.85B | ---- | ---- | ---- | ---- | 1.02%1.68B | ---- | ---- | ---- | ---- |
Research and development costs | 29.72%1.51B | ---- | ---- | ---- | ---- | 9.43%1.16B | ---- | ---- | ---- | ---- |
Other operating expenses | 0.20%4.44B | ---- | ---- | ---- | ---- | 32.55%4.43B | ---- | ---- | ---- | ---- |
Operating profit | -42.12%2.82B | 90.91%819M | -1.54%1.08B | -72.12%469M | -72.98%449M | -17.09%4.87B | -63.67%429M | -29.06%1.1B | 6.05%1.68B | 6.54%1.66B |
Net non-operating interest income (expenses) | -64.29%-23M | -25.00%-5M | -50.00%-6M | -75.00%-7M | -150.00%-5M | -27.27%-14M | -33.33%-4M | -100.00%-4M | -33.33%-4M | 33.33%-2M |
Non-operating interest income | --1M | --1M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Non-operating interest expense | 71.43%24M | 50.00%6M | 50.00%6M | 75.00%7M | 150.00%5M | 27.27%14M | 33.33%4M | 100.00%4M | 33.33%4M | -33.33%2M |
Net investment income | 1,140.00%52M | 77.05%-14M | 92.31%50M | 0 | 433.33%16M | -225.00%-5M | -238.89%-61M | 160.00%26M | 27M | -75.00%3M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 128M | 0 | 0 | 0 | 128M | 0 | 0 | 0 | ||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -84.34%-153M | -224.24%-107M | -66.67%-20M | 0 | 13.33%-26M | 35.66%-83M | 10.81%-33M | 62.50%-12M | 68.00%-8M | 14.29%-30M |
Less:Other special charges | 0.00%65M | 66.67%25M | 66.67%20M | --0 | -33.33%20M | -43.48%65M | -50.00%15M | -62.50%12M | -68.00%8M | 7.14%30M |
Less:Write off | 388.89%88M | 355.56%82M | --0 | --0 | --6M | 28.57%18M | 157.14%18M | --0 | --0 | --0 |
Other non-operating income (expenses) | 128.19%429M | -42.96%77M | -13.33%13M | 322.22%40M | 433.93%299M | 6.82%188M | 170.00%135M | -68.75%15M | -162.07%-18M | 14.29%56M |
Income before tax | -34.42%3.25B | 66.02%767M | -0.71%1.12B | -69.92%505M | -49.11%859M | -16.22%4.96B | -60.51%462M | -28.47%1.13B | 5.66%1.68B | 6.77%1.69B |
Income tax | -27.23%1.13B | 115.71%302M | 1.68%364M | -66.67%182M | -44.44%285M | 6.57%1.56B | 52.17%140M | -21.15%358M | 19.21%546M | 12.25%513M |
Net income | -37.72%2.12B | 44.10%464M | -1.82%756M | -71.47%323M | -51.15%574M | -23.70%3.4B | -70.13%322M | -31.37%770M | 0.09%1.13B | 4.54%1.18B |
Net income continuous operations | -37.71%2.12B | 44.41%465M | -1.82%756M | -71.49%323M | -51.15%574M | -23.70%3.4B | -70.13%322M | -31.43%770M | 0.18%1.13B | 4.54%1.18B |
Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to the company | -37.72%2.12B | 44.10%464M | -1.69%757M | -71.58%322M | -51.11%574M | -23.70%3.4B | -70.13%322M | -31.37%770M | 0.18%1.13B | 4.45%1.17B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -37.72%2.12B | 44.10%464M | -1.69%757M | -71.58%322M | -51.11%574M | -23.70%3.4B | -70.13%322M | -31.37%770M | 0.18%1.13B | 4.45%1.17B |
Gross dividend payment | ||||||||||
Basic earnings per share | -37.54%185.21 | 46.01%40.97 | -1.68%66.04 | -71.51%28.14 | -51.18%50.06 | -23.74%296.54 | -70.16%28.06 | -31.41%67.17 | 0.06%98.78 | 4.45%102.53 |
Diluted earnings per share | -37.54%185.21 | 45.84%40.9215 | -1.68%66.04 | -71.57%28.0795 | -51.18%50.06 | -23.74%296.54 | -70.16%28.06 | -31.41%67.17 | 0.06%98.78 | 4.45%102.53 |
Dividend per share | 0.00%110 | 0.00%55 | 0 | 0.00%55 | 0 | 0.00%110 | 0.00%55 | 0 | 0.00%55 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |